Jane Street’s Fibrocell Science Inc. FCSC Stock Holding History

Jane Street’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-13,080	Closed	-$20K	–	5986
2018 Q4	$20K	Buy	+13,080	New	+$26.2K	﹤0.01%	4795

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street's FCSC Position: Q1 2019 in Review

Jane Street sold out of Fibrocell Science Inc. (FCSC) in Q1 2019, closing a stake of 13,080 shares — an estimated $20K sold.

Jane Street first reported a position in FCSC in Q4 2018 and held it in 1 quarter. The position peaked at $20K in Q4 2018. 23 funds tracked by Wall St. Rank hold FCSC as of Q1 2019.

Jane Street reported no remaining Fibrocell Science Inc. position as of Q1 2019 after selling out during the quarter.
Jane Street sold 13,080 Fibrocell Science Inc. shares in Q1 2019, an estimated $20K.
Jane Street first reported a position in Fibrocell Science Inc. in Q4 2018 and held it in 1 quarter.
Jane Street's Fibrocell Science Inc. position peaked at $20K in Q4 2018.
23 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2019.

Based on Jane Street's 13F filing for Q1 2019, filed 16 May 2019.